Werner Enterprises (WERN) announced its third quarter earnings after the bell on Thursday, posting a 1% change in revenues from last year’s Q3, but a 15% drop in net income.
The Omaha, NE-based logistics and transportation company announced Q3 revenue of $511.73 million, which was up slightly from last year’s $506.50 million revenue figure. WERN reported net income for the quarter of $21.53 million, or 29 cents per diluted share, which was down from last year’s Q3 earnings of $25.13 million, or 34 cents per diluted share.
The company was able to meet analyst views of 29 cents EPS, and slightly surpass the revenue estimate of $503.82 million.
Top 5 India Companies To Watch For 2015: Centrex Metals Ltd (CXM)
Centrex Metals Limited (Centrex) is an Australia-based company engaged in iron ore exploration on wholly owned tenements in conjunction with joint venture partners Wuhan Iron & Steel (Group) Co. (WISCO) and Baotou Iron & Steel (Group) Co. (Baotou). The Company�� principal projects include WISCO joint ventures (Eyre Iron: Centrex 40%, Port Spencer: Centrex 50%), Bungalow joint venture (Centrex 70%), Wilgerup (Centrex 100%) and Exploration (Centrex 100%). The Bungalow / Minbrie magnetite deposit is located 9 kilometers north of the coastal town of Cowell on the Eyre Peninsula and around 100 kilometers from the Port Spencer joint venture site. The Goulburn and Archer tenements cover an extensive area with a number of base metal, gold and iron deposits and occurrences. Advisors' Opinion:- [By James E. Brumley]
To say that Cardium Therapeutics Inc. (NYSEMKT:CXM) has been unimpressive this year - and last year for that matter - would be an understatement. Shares of CXM peaked at $11.90 in late 2011, and spend the next two years making their way back to the August (2013) low of $0.58. The stock has since wiggled its way back to the current price of $0.84, but the effort has largely been dismissed as volatility. Big mistake. When you take a step back and look at the bigger picture, you start to see Cardium Therapeutics shares are on the cusp of a monster-sized rebound.
5 Best Logistics Stocks For 2014: Tencent Holdings Ltd (TCTZF)
Tencent Holdings Limited is an investment holding company. The Company and its subsidiaries are principally engaged in the provision of Internet value-added services, mobile and telecommunications value-added services and online advertising services to users in the People�� Republic of China. The Company operates in four segments: Internet value-added services, Mobile and telecommunications value-added services, Online advertising, and Others. As of December 31, 2011, its subsidiaries included Tencent Cyber (Tianjin) Company Limited, Tencent Asset Management Limited, Tencent Technology (Beijing) Company Limited, Tencent Cyber (Shenzhen) Company Limited, Tencent Technology (Shanghai) Company Limited and others. Advisors' Opinion:- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Chinese stocks fell early Wednesday, joining a broadly negative day for regional trade in the wake of overnight losses on Wall Street. Hong Kong's Hang Seng Index (HK:HSI) dropped by 0.5% to 23,625.77, with the Hang Seng China Enterprises Index 0.8% lower, while the Shanghai Composite (CN:SHCOMP) fell 0.7%. Top-weighted Hang Seng component HSBC Holdings PLC (HK:5) fell 0.5%, while fellow international lender Standard Chartered PLC (HK:2888) (UK:STAN) lost 1.4%, with some reports linking the losses to the approval of the so-called Volcker rule in the U.S. which prohibits most proprietary trading by banks there. The Financial Times also cited concerns about possible cash-calls as weighing on Standard Chartered. Meanwhile, ratings moves influenced some shares. Jiangxi Copper Co. (HK:358) (JIXAY) retreated 1%, and China Shenhua Energy Co. (HK:1088) (CUAEF) dropped 1.4% after Credit Suisse cut both stocks to neutral, according to Kim Eng Securities. However, Tencent Holdings Ltd. (HK:700) (TCTZF) added 1.5% to its price after Deutsche Bank upped the Internet content provider's rating to buy. Also bucking the downtrend, China Overseas Land & Investment Ltd. (HK:688) (CAOVF) gained
- [By MARKETWATCH]
HONG KONG (MarketWatch) -- Hong Kong stocks sold off early Thursday after the Federal Reserve decided to further taper stimulus, and after a final reading of China's manufacturing PMI contracted. The Hang Seng Index (HK:HSI) sank 1.5% to 21,815.04 in holiday-shortened trading. Tech stocks retreated, as Chinese PC maker Lenovo Group Ltd. (HK:992) (LNVGF) dropped 5.3%, failing to get a lift from news that it plans to acquire the Motorola handset business from Google Inc. (GOOG) for $2.91 billion as Lenovo aims for a bigger presence in the U.S. market. Software developer Kingsoft Corp. (HK:3888) (KSFTF) fell 1.9% and Internet giant Tencent Holdings Ltd. (HK:700) (TCTZF) dropped 1.5%. Casino stocks also declined. Sands China Ltds. (HK:1928) (SCHYF) , the Hong Kong-listed unit of Las Vegas Sands Corp. (LVS) , slipped 0.2%, despite financial results that showed Sands China's net income increased 40% year-on-year to $467 million in the fourth quarter. Melco Crown Entertainment Ltd. (HK:6883) (MPEL) slumped 3.2%, and both Wynn Macau Ltd. (HK:1128) (WYNMF) and MGM China Holdings Ltd. (HK:2282)
- [By Craig Stephen]
Still, this pilot scheme offers something new to mainland investors. They can now invest in sectors of the economy which were previously off limits, giving more choice outside the old state-owned industries. This will include areas such as Macau gaming and Internet stocks. One of the largest, traded stocks in Hong Kong is Tencent (HK:0700) � (TCTZF) , which is likely to be added to mainland portfolios.
- [By Jim Jubak]
In Asia today, Tencent Holdings ((HK:700) in Hong Kong and (TCTZF) in New York) closed down 5.9% in Hong Kong. The company, know for its WeChat mobile messaging platform (with 355 million average monthly users), made $100 million in revenue in the fourth quarter from games, such as Cross Fire and League of Legends on the WeChat platform. Naver (KS:035420), a Korean company that, like Tencent, combines mobile messaging with games, dropped 3% in Seoul.
5 Best Logistics Stocks For 2014: Albany Molecular Research Inc.(AMRI)
Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States, Europe, and Asia. The company offers a range of drug discovery services, including assay development and design, screening, screening library, natural product, medicinal chemistry, computer-aided drug discovery, in vitro ADMET, and bioanalytical services. It also provides chemical development services consisting of process research and development, custom synthesis, process safety assessment, scale-up capabilities, high potency and controlled substances, analytical services, preformulation services and physical characterization, preparative chromatography, IND support services, fermentation development and optimization, and building blocks collection and database services. In addition, the company offers chemical synthesis and manufacturing services. It manufactures active pharmaceutical ingredients (APIs)and advanced intermediate s. Further, the company provides contract manufacturing services in sterile syringe and vial filling for small molecule drug products and biologicals. Additionally, it offers formulation services, including neat API or pharmaceutical blend in capsules; PIB for solution and suspension; blending and sieving; milling; tableting; rheology; roller compaction; wet granulation; and fluid bed processing, including wurster coating; and associated analytical testing services for dosage formulation products, as well as provides analytical services, such as impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; analytical and preparative supercritical fluid chromatography; preparative chromatography; good laboratory practices bioanalytical services; and regulatory support/quality assurance services. The company was founded in 1991 and is based in Albany, New York.
Advisors' Opinion:- [By Garrett Cook]
Shares of Albany Molecular Research (NASDAQ: AMRI) were down 22.34 percent to $17.61 after the company reported a Q3 loss of $0.02 per share on revenue of $62.47 million.
- [By Jake L'Ecuyer]
Among the sector stocks, Albany Molecular Research (NASDAQ: AMRI) was down more than 13 percent, while Sangamo Biosciences (NASDAQ: SGMO) tumbled around 6 percent.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV).
5 Best Logistics Stocks For 2014: Athersys Inc.(ATHX)
Athersys, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic products in various disease areas in the United States. Its clinical development programs are focused on treating cardiovascular disease, neurological conditions, inflammatory and immune disorders, and other conditions. Its product pipeline includes MultiStem, a novel allogeneic approach to stem cell therapy and regenerative medicine for treating a range of diseases. The company is also involved in the development of novel small molecule compounds for applications in indications, such as obesity and other areas, including the treatment of neurological conditions, and for the modulation of stem cells or related applications in the regenerative medicine area. It has product co-development collaboration with Pfizer Inc. to develop and commercialize MultiStem to treat inflammatory bowel disease for the worldwide market; Angiotech Pharmaceuticals, Inc. to develop and commerciali ze MultiStem to treat certain cardiovascular diseases, such as acute myocardial infarction; and RTI Biologics, Inc. to develop and commercialize biologic implants for certain orthopedic applications in the bone graft substitutes market. The company was founded in 1995 and is based in Cleveland, Ohio.
Advisors' Opinion:- [By GuruFocus]
George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated
- [By Roberto Pedone]
Athersys (ATHX) is a biopharmaceutical company focused in the field of regenerative medicine. This stock closed up 4% to $1.79 in Thursday's trading session.
Thursday's Range: $1.68-$1.80
52-Week Range: $0.95-$2.42
Thursday's Volume: 270,000
Three-Month Average Volume: 323,188From a technical perspective, ATHX bounced notably higher here right off its 50-day moving average of $1.67 with decent upside volume. This stock recently pulled back from $1.99 to its 50-day at $1.67. Shares of ATHX may now be down with that pullback, since the stock is starting to trend higher and move within range of triggering a near-term breakout trade. That trade will hit if ATHX manages to take out some near-term overhead resistance levels at $1.90 to $1.99 with high volume.
Traders should now look for long-biased trades in ATHX as long as it's trending above its 50-day at $1.67 and then once it sustains a move or close above those breakout levels with volume that hits near or above 323,188 shares. If that breakout triggers soon, then ATHX will set up to re-test or possibly take out its next major overhead resistance levels at $2.16 to $2.25. Any high-volume move above those levels will put its 52-week high at $2.42 into range for shares of ATHX.
No comments:
Post a Comment